Alerts
Bladder Cancer Surgery Just Became a System Test
The FDA has expanded perioperative pembrolizumab plus enfortumab vedotin to all cystectomy-eligible adults with muscle-invasive bladder cancer. The approval is clinical progress. The implementation burden now moves to hospitals.
Andes Virus on a Cruise Ship Turns Quarantine Into a Travel-Health Test
The WHO’s first stroke resolution turns a clinical problem into a political one
Personalised Cancer Vaccines Show Longer-Term Staying Power
China’s PD-1/VEGF Bet Challenges the Lung Cancer Backbone
High-Risk Prostate Cancer Moves Before the Metastatic Clock Starts
Servier’s $2.65B Muscular Dystrophy Deal Turns Rare Neurology Into a Commercial Priority
Lenacapavir Turns HIV Prevention Into an Access Stress Test
WHO’s New AMR Plan Makes Stewardship and Access a Single Test
Can cortisol become the next target in type 2 diabetes?
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.